About Khandelwal Laboratories
Khandelwal Laboratories is a company based in Mumbai (India) founded in 1945. Khandelwal Laboratories has raised $459.28 thousand across 1 funding round from investors including Sanjeev Khandelwal. The company has 810 employees as of March 18, 2025. Khandelwal Laboratories offers products and services including Oncology Products, Antibiotics, Niche APIs, and NDDS Formulations. Khandelwal Laboratories operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
- Headquarter Mumbai, India
- Employees 810 as on 18 Mar, 2025
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Khandelwal Laboratories Pvt Ltd
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$27.52 M (USD)10.42as on Mar 31, 2024
-
Net Profit
$317.78 K (USD)64.03as on Mar 31, 2024
-
EBITDA
$905.37 K (USD)138.44as on Mar 31, 2024
-
Total Equity Funding
$459.28 K (USD)
in 1 rounds
-
Latest Funding Round
$459.28 K (USD), Unspecified
Mar 30, 2007
-
Investors
-
Employee Count
810
as on Mar 18, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Khandelwal Laboratories
Khandelwal Laboratories offers a comprehensive portfolio of products and services, including Oncology Products, Antibiotics, Niche APIs, and NDDS Formulations.
Drugs for cancer treatment and management in patients.
Medications to combat bacterial infections effectively.
Active ingredients for specialized drug formulations.
Advanced delivery systems for targeted drug administration.
People of Khandelwal Laboratories
Unlock access to complete
Funding Insights of Khandelwal Laboratories
Khandelwal Laboratories has successfully raised a total of $459.28K through 1 strategic funding round. The most recent funding activity was a Unspecified round of $459.28 thousand completed in March 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Khandelwal Laboratories
Khandelwal Laboratories has secured backing from 1 investor, including angel investors. Prominent investors backing the company include Sanjeev Khandelwal.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
SK
Sanjeev Khandelwal |
-
|
Locked | Locked | Locked |
Investor details for Khandelwal Laboratories
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Khandelwal Laboratories
Investment portfolio details for Khandelwal Laboratories
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Khandelwal Laboratories
Detailed financials for Khandelwal Laboratories
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Khandelwal Laboratories Comparisons
Peer comparison for Khandelwal Laboratories
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Khandelwal Laboratories
Khandelwal Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| Locked | Locked | Locked |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| Locked | Locked | Locked |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| Locked | Locked | Locked |
APIs and finished products are developed and manufactured.
|
|
| Locked | Locked | Locked |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| Locked | Locked | Locked |
APIs and peptides are developed and manufactured by Asymchem.
|
Detailed competitors of Khandelwal Laboratories
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Khandelwal Laboratories
Complete news archive for Khandelwal Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Khandelwal Laboratories
Khandelwal Laboratories was founded in 1945 and raised its 1st funding round 62 years after it was founded.
Khandelwal Laboratories is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Khandelwal Laboratories is a funded company, having raised a total of $459.28K across 1 funding round to date.
As of Mar 18, 2025, the latest employee count at Khandelwal Laboratories is 810.
Annual revenue of Khandelwal Laboratories is $27.52M as on Mar 31, 2024.
Khandelwal Laboratories manufactures, markets and out-licenses patented pharmaceutical formulations, NDDS, APIs and chiral intermediates. It is marketing its generic products in various therapeutic segments such as anaesthetics, antihypertensives, anti- ulcer agents, antiasthmatic, anti-diabetic, anti-fungal, antihistamines, antimicrobials, NSAIDs etc. It also manufactures APIs, formulations (branded generics) for oncology treatment and also offers CMO services. Their WHO GMP approved manufacturing facility is capable of manufacturing tablets, capsules and injections (liquids and lyophilized). The company claims to have 222 patents (granted and pending) in the areas of NDDS, nanotechnology, dendrimers and chiral chemistry.
Khandelwal Laboratories's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
Khandelwal Laboratories offers Oncology Products, Antibiotics, Niche APIs, and NDDS Formulations.
Khandelwal Laboratories has 1 investor. Key investors include Sanjeev Khandelwal.
The valuation of Khandelwal Laboratories is $1.16M as of Mar 2007.